Related Experiment Video
Updated: Jun 26, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Characteristics and spectrum changes of PICU cases during the COVID-19 pandemic: a retrospective analysis
Yufan Yang1, Yueqi He1, Jiaotian Huang1
1Department of Intensive Care Unit, Affiliated School of Medicine of Central South University (Hunan Children's Hospital), Changsha, Hunan, China.
Insights
The COVID-19 pandemic reduced pediatric intensive care unit admissions and respiratory illnesses, with lower mortality. Future PICU care should prioritize respiratory, neurological, and hematological oncology systems.
Area of Science:
- Pediatric Intensive Care
- Epidemiology
- Infectious Diseases
Background:
- The COVID-19 pandemic significantly altered healthcare delivery globally.
- Understanding its impact on pediatric critical care is crucial for adapting medical strategies.
Purpose of the Study:
- To compare the disease spectrum of children in Pediatric Intensive Care Units (PICUs) during the COVID-19 pandemic with the pre-pandemic period.
- To analyze the pandemic's influence on PICU patient demographics and disease patterns.
Main Methods:
- Retrospective analysis of critically ill children admitted to Hunan Children's Hospital PICU.
- Comparison of data from the pandemic period (2020-2022) with the pre-pandemic period (2017-2019).
- Analysis of general characteristics, age, gender, disease spectrum, mortality, length of stay, and hospitalization costs.
Main Results:
- A 31.62% decrease in overall PICU admissions during the pandemic.
- A 52.78% reduction in the proportion of respiratory system diseases.
- An 87.81% decrease in overall mortality rate.
- Significant differences in age and gender distribution; no significant change in hospital stay duration, but altered hospitalization costs.
Conclusions:
- The COVID-19 pandemic influenced the disease spectrum in PICU admissions.
- Pandemic-related measures helped reduce pediatric respiratory diseases.
- Future PICU clinical strategies should prioritize respiratory, neurological, and hematological oncology systems based on observed changes.
Objective:
This study aims to compare the changes in the disease spectrum of children admitted to the Pediatric Intensive Care Units (PICU) during the COVID-19 pandemic with the three years prior to the pandemic, exploring the impact of the COVID-19 pandemic on the disease spectrum of PICU patients.
Methods:
A retrospective analysis was conducted on critically ill children admitted to the PICU of Hunan Children's Hospital from January 2020 to December 2022, and the results were compared with cases from the same period between January 2017 and December 2019. The cases were divided into pre-pandemic period (January 2017-December 2019) with 8,218 cases, and pandemic period (January 2020-December 2022) with 5,619 cases. General characteristics, age, and gender were compared between the two groups.
Results:
Compared to the pre-pandemic period, there was a 31.62% decrease in the number of admitted children during the pandemic period, and a 52.78% reduction in the proportion of respiratory system diseases. The overall mortality rate decreased by 87.81%. There were differences in age and gender distribution between the two periods. The length of hospital stay during the pandemic showed no statistical significance, whereas hospitalization costs exhibited statistical significance.
Conclusion:
The COVID-19 pandemic has exerted a certain influence on the disease spectrum of PICU admissions. Implementing relevant measures during the pandemic can help reduce the occurrence of respiratory system diseases in children. Considering the changes in the disease spectrum of critically ill PICU children, future clinical prevention and treatment in PICUs should continue to prioritize the respiratory, neurological, and hematological oncology systems.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...